Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), S. A. S. Nagar, Mohali, 160062, Punjab, India.
J Org Chem. 2012 Sep 21;77(18):8321-8. doi: 10.1021/jo301065s. Epub 2012 Sep 7.
Concerted metalation deprotonation (CMD) approach with appropriate proton shuttle precursor, base, and solvent (PivOH-K(2)CO(3)-toluene) has rendered a regioselective Pd-catalyzed C6-arylation of 3-aminoimidazo[1,2-a]pyrazine, a therapeutically relevant scaffold accessible by multicomponent reaction. The arylation of this heteroarene suffers from competing C5 and C2'-arylation reactions, while the developed process has virtually eliminated these competing arylations. Density functional calculations for CMD C-H activation at C6, C5, C8, and C2' sites imply that the energy barrier with distortion energy penalty as major contributing component influences the regioselectivity.
协同去质子化(CMD)方法与合适的质子穿梭前体、碱和溶剂(PivOH-K2CO3-甲苯)一起使用,实现了 3-氨基咪唑并[1,2-a]吡嗪的区域选择性 Pd 催化 C6-芳基化,这是一种通过多组分反应可获得的具有治疗相关性的支架。该杂芳环的芳基化受到竞争的 C5 和 C2'-芳基化反应的影响,而开发的工艺实际上消除了这些竞争的芳基化反应。CMD C-H 在 C6、C5、C8 和 C2' 位点的活化的密度泛函计算表明,作为主要贡献组成部分的构象能罚的能量势垒影响区域选择性。